These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 17418569

  • 1. Ligand based virtual screening and biological evaluation of inhibitors of chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv.
    Agrawal H, Kumar A, Bal NC, Siddiqi MI, Arora A.
    Bioorg Med Chem Lett; 2007 Jun 01; 17(11):3053-8. PubMed ID: 17418569
    [Abstract] [Full Text] [Related]

  • 2. When inhibitors do not inhibit: critical evaluation of rational drug design targeting chorismate mutase from Mycobacterium tuberculosis.
    Munack S, Leroux V, Roderer K, Ökvist M, van Eerde A, Gundersen LL, Krengel U, Kast P.
    Chem Biodivers; 2012 Nov 01; 9(11):2507-27. PubMed ID: 23161632
    [Abstract] [Full Text] [Related]

  • 3. Discovery and structure optimization of a series of isatin derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.
    Jeankumar VU, Alokam R, Sridevi JP, Suryadevara P, Matikonda SS, Peddi S, Sahithi S, Alvala M, Yogeeswari P, Sriram D.
    Chem Biol Drug Des; 2014 Apr 01; 83(4):498-506. PubMed ID: 24636345
    [Abstract] [Full Text] [Related]

  • 4. Identification and structure-activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.
    Alokam R, Jeankumar VU, Sridevi JP, Matikonda SS, Peddi S, Alvala M, Yogeeswari P, Sriram D.
    J Enzyme Inhib Med Chem; 2014 Aug 01; 29(4):547-54. PubMed ID: 24090423
    [Abstract] [Full Text] [Related]

  • 5. Mycobacterium tuberculosis chorismate mutase: A potential target for TB.
    Khanapur M, Alvala M, Prabhakar M, Shiva Kumar K, Edwin RK, Sri Saranya PS, Patel RK, Bulusu G, Misra P, Pal M.
    Bioorg Med Chem; 2017 Mar 15; 25(6):1725-1736. PubMed ID: 28202315
    [Abstract] [Full Text] [Related]

  • 6. Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints.
    Kumar A, Chaturvedi V, Bhatnagar S, Sinha S, Siddiqi MI.
    J Chem Inf Model; 2009 Jan 15; 49(1):35-42. PubMed ID: 19063713
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A virtual screening approach for thymidine monophosphate kinase inhibitors as antitubercular agents based on docking and pharmacophore models.
    Gopalakrishnan B, Aparna V, Jeevan J, Ravi M, Desiraju GR.
    J Chem Inf Model; 2005 Jan 15; 45(4):1101-8. PubMed ID: 16045305
    [Abstract] [Full Text] [Related]

  • 10. The 2.15 A crystal structure of Mycobacterium tuberculosis chorismate mutase reveals an unexpected gene duplication and suggests a role in host-pathogen interactions.
    Qamra R, Prakash P, Aruna B, Hasnain SE, Mande SC.
    Biochemistry; 2006 Jun 13; 45(23):6997-7005. PubMed ID: 16752890
    [Abstract] [Full Text] [Related]

  • 11. A comparative biochemical and structural analysis of the intracellular chorismate mutase (Rv0948c) from Mycobacterium tuberculosis H(37)R(v) and the secreted chorismate mutase (y2828) from Yersinia pestis.
    Kim SK, Reddy SK, Nelson BC, Robinson H, Reddy PT, Ladner JE.
    FEBS J; 2008 Oct 13; 275(19):4824-35. PubMed ID: 18727669
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Novel alkynyl substituted 3,4-dihydropyrimidin-2(1H)-one derivatives as potential inhibitors of chorismate mutase.
    Mallikarjuna Rao V, Mahesh Kumar P, Rambabu D, Kapavarapu R, Shobha Rani S, Misra P, Pal M.
    Bioorg Chem; 2013 Dec 13; 51():48-53. PubMed ID: 24012092
    [Abstract] [Full Text] [Related]

  • 14. Biochemical and structural characterization of the secreted chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv: an *AroQ enzyme not regulated by the aromatic amino acids.
    Kim SK, Reddy SK, Nelson BC, Vasquez GB, Davis A, Howard AJ, Patterson S, Gilliland GL, Ladner JE, Reddy PT.
    J Bacteriol; 2006 Dec 13; 188(24):8638-48. PubMed ID: 17146044
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of novel antitubercular compounds through hybrid virtual screening approach.
    Muddassar M, Jang JW, Hong SK, Cho YS, Kim EE, Keum KC, Oh T, Cho SN, Pae AN.
    Bioorg Med Chem; 2010 Sep 15; 18(18):6914-21. PubMed ID: 20727773
    [Abstract] [Full Text] [Related]

  • 20. Cluster-based molecular docking study for in silico identification of novel 6-fluoroquinolones as potential inhibitors against Mycobacterium tuberculosis.
    Minovski N, Perdih A, Novic M, Solmajer T.
    J Comput Chem; 2013 Apr 05; 34(9):790-801. PubMed ID: 23280926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.